certain
virus
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
ebola
viru
ebov
subtyp
avian
influenza
viru
highli
infecti
highli
pathogen
present
tremend
difficulti
danger
research
contrast
pseudoviru
technolog
safe
effect
research
tool
briefli
pseudoviru
type
retroviru
integr
envelop
glycoprotein
anoth
type
viru
form
new
viru
exogen
viral
envelop
genom
maintain
characterist
retrovir
genom
compar
natur
virus
pseudovirus
integr
envelop
protein
anoth
viru
use
envelop
proteinencod
gene
within
modifi
nucleic
acid
molecul
pseudovirus
accomplish
one
infect
cycl
lose
selfrepl
abil
thu
pseudovirus
biolog
safe
infecti
virus
pseudovirus
also
extens
host
rang
higher
transfect
effici
easili
concentr
origin
virus
defend
deactiv
function
serum
complement
noncellcycledepend
integr
featur
effici
transfect
quiescent
cell
pseudoviru
prepar
thu
effect
safe
reliabl
method
applic
studi
virus
high
pathogen
difficult
cultur
vitro
pseudovirus
rel
safe
advantag
extens
host
rang
noncellcycledepend
highli
effici
transfect
quiescent
cell
particularli
import
role
studi
virushost
cell
interact
neutral
antibodi
titer
evalu
gene
therapi
thu
pseudovirus
use
novel
safe
experiment
tool
rift
valley
fever
viru
rvfv
rna
viru
phleboviru
genu
bunyavirida
famili
particular
rvfv
highrisk
pathogen
induc
fatal
enceph
hemorrhag
fever
human
rumin
due
strong
pathogen
fast
dissemin
rvfv
attract
consider
worldwid
attent
current
viral
isol
hemagglutin
inhibit
assay
enzymelink
immunosorb
assay
elisa
agar
gel
immunodiffus
assay
immunofluoresc
assay
radioimmunoassay
complement
fixat
assay
primari
method
use
detect
rvfv
addit
clinic
detect
antirvfv
antibodi
primarili
accomplish
use
elisa
method
commonli
use
coat
antigen
includ
envelop
protein
gn
inactiv
rvfv
howev
method
preliminarili
detect
antibodi
level
human
result
truli
reflect
whether
antibodi
pathogenneutr
antirvfv
antiinfect
function
therefor
viru
neutral
assay
becom
import
clinic
method
measur
antibodi
activ
evalu
immun
statu
human
neutral
assay
typic
use
natur
virus
caus
infect
assay
oper
pose
risk
viral
spread
thu
assay
consid
danger
avoid
potenti
risk
associ
neutral
assay
present
studi
use
lentivir
packag
system
target
rvfv
structur
protein
construct
rvfv
pseudovirus
replac
live
virus
pseudovirus
use
establish
rvfv
neutral
assay
method
allow
effect
evalu
human
antibodi
titer
escherichia
coli
compet
cell
recombin
plasmid
contain
gn
gc
sequenc
rvfv
gene
cell
eukaryot
express
plasmid
obtain
anim
virolog
special
diseas
research
laboratori
militari
veterinari
research
institut
academi
militari
medic
scienc
china
enhanc
express
codon
optim
perform
gprotein
gene
sequenc
rvfv
strain
clone
primer
design
base
optim
sequenc
kpn
restrict
site
introduc
end
upstream
downstream
primer
primer
synthes
sangon
biotech
china
recombin
plasmid
use
templat
polymeras
chain
reaction
pcr
amplif
perform
synthes
primer
obtain
dna
fragment
subject
doubl
digest
ligat
doubledigest
eukaryot
express
plasmid
recombin
plasmid
confirm
correct
ligat
gene
sequenc
perform
beij
genom
institut
china
final
recombin
express
plasmid
extract
futur
use
name
plasmid
use
transfect
extract
use
endotoxinfre
plasmid
extract
reagent
kit
endo
free
plasmid
dna
mini
kit
ii
omega
china
twentyfour
hour
transfect
cell
inocul
onto
plate
corn
usa
densiti
cellsml
ml
dulbecco
modifi
eagl
medium
dmem
gibco
usa
contain
fetal
bovin
serum
fb
thermo
usa
cell
cultur
cell
growth
reach
confluenc
lentivir
plasmid
plvegfpc
invitrogen
usa
plasmid
invitrogen
recombin
plasmid
plasmid
use
posit
control
transfect
cell
use
lipofectamin
transfect
reagent
invitrogen
cell
cultur
h
cultur
medium
replac
ml
fresh
cultur
medium
h
transfect
cultur
medium
replac
ml
fresh
viru
cultur
medium
h
transfect
cell
cultur
supernat
collect
place
ml
centrifug
tube
centrifug
g
min
supernat
collect
filter
filter
transfer
new
ml
centrifug
tube
final
filtrat
transfer
centrifug
filter
devic
centrifug
g
min
liquid
bottom
layer
discard
filtrat
centrifug
g
min
solut
top
layer
filter
devic
viru
concentr
virus
aliquot
store
rvfv
pseudoviru
packag
condit
identifi
use
electron
microscopi
western
blot
electron
microscopi
detect
process
harvest
pseudovirus
pseudoviru
concentr
first
adsorb
copper
grid
stain
phosphotungst
acid
sigma
usa
min
residu
stain
solut
absorb
use
filter
paper
pseudoviru
particl
observ
use
electron
microscop
addit
cell
supernat
collect
transfect
mix
protein
load
buffer
use
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
thermo
dilut
ad
ml
centrifug
tube
sampl
mix
thoroughli
boil
min
sampl
use
western
blot
detect
analysi
experiment
western
blot
process
membran
block
thermo
membraneblock
solut
contain
bovin
serum
albumin
h
room
temperatur
membran
next
incub
rabbit
polyclon
primari
antibodi
dilut
ibt
bioservic
usa
h
room
temperatur
hrplabel
goat
antimous
igg
secondari
antibodi
invitrogen
h
room
temperatur
blot
develop
chemiluminesc
develop
solut
thermo
experiment
data
store
system
fujifilm
japan
confirm
multipl
infect
pseudovirus
obtain
stabl
infect
effect
measur
rvfv
pseudoviru
titer
specif
harvest
purifi
viru
solut
use
determin
viral
titer
although
frozen
viru
solut
could
use
notabl
larg
differ
detect
viral
titer
measur
use
differ
cell
line
method
thu
larg
differ
might
exist
viral
titer
valu
viral
titer
requir
infect
target
cell
avoid
issu
viru
solutionbas
measur
method
use
determin
viral
titer
order
provid
accur
measur
viru
packag
effect
next
cell
cultur
logarithm
growth
phase
dissoci
trypsin
gibco
count
cell
seed
cultur
plate
densiti
cellswel
cultur
viru
inocul
pseudoviru
solut
store
freezer
thaw
ice
bath
subject
seri
gradient
dilut
use
dmem
contain
fb
dilut
ad
three
replic
well
cell
cultur
overnight
cultur
medium
replac
dmem
contain
fb
cell
continu
cultur
h
cell
observ
via
fluoresc
microscopi
number
cell
posit
green
fluoresc
well
calcul
viru
titer
number
cell
posit
green
fluoresc
multipli
correspond
fold
dilut
polyclon
antibodi
rvfv
gprotein
dilut
ibt
bioservic
dilut
healthi
mous
serum
use
neg
control
antibodi
rvfvvesicular
stomat
viru
vsv
g
pseudoviru
solut
iu
mix
equal
volum
ad
cell
cultur
plate
incub
h
next
mixtur
ad
cell
logarithm
growth
phase
contain
cell
mix
thoroughli
cell
cultur
h
number
cell
posit
fluoresc
well
determin
via
fluoresc
microscopi
serum
sampl
collect
rvfv
gproteinimmun
mice
use
gener
serial
dilut
next
dilut
antibodi
rvfv
pseudovirusvsv
pseudoviru
use
neg
control
iu
mix
equal
volum
incub
h
subsequ
cell
cell
ad
well
cultur
h
final
experiment
result
collect
observ
fluoresc
microscop
antibodi
neutral
activ
calcul
accord
formula
antibodi
neutral
activ
number
cell
posit
green
fluoresc
control
group
number
cell
posit
green
fluoresc
experiment
group
number
cell
posit
green
fluoresc
control
group
rvfv
structur
gene
obtain
appli
pcr
amplif
method
amplifi
fragment
length
bp
shown
fig
recombin
plasmid
use
amplif
templat
result
assess
carri
agaros
gel
electrophoresi
one
band
present
approxim
bp
consist
size
bp
expect
target
fragment
result
indic
correct
target
gene
band
amplifi
pcr
gene
sequenc
analysi
restrict
endonucleas
digest
use
valid
construct
recombin
plasmid
plasmid
digest
kpn
enzym
evalu
perform
agaros
gel
electrophoresi
fig
result
show
two
nucleic
acid
band
approxim
bp
bp
consist
target
gene
fragment
bp
empti
plasmid
bp
respect
result
verifi
correct
insert
target
fragment
gene
fragment
obtain
experi
target
gene
sequenc
obtain
use
gene
sequenc
homolog
indic
recombin
plasmid
correctli
construct
rvfv
pseudoviru
packag
condit
observ
via
electron
microscopi
viru
solut
harvest
h
cotransfect
mix
lentivir
plasmid
cell
spheric
particl
envelop
nm
diamet
observ
use
electron
microscop
particl
morpholog
structur
consist
previous
report
descript
human
immunodefici
viru
hiv
lentivir
vector
result
indic
recombin
plasmid
obtain
studi
could
packag
cell
produc
pseudovirus
fig
confirm
acquir
viral
particl
rvfv
pseudovirus
western
blot
perform
determin
whether
pseudoviru
envelop
protein
compos
rvfv
structur
protein
supernat
cell
transfect
examin
use
rabbit
polyclon
antibodi
fig
western
blot
result
show
two
specif
band
molecular
weight
approxim
kda
kda
consist
size
rvfv
protein
respect
neg
control
group
show
specif
band
result
indic
target
protein
correctli
express
moreov
western
blot
detect
result
indic
obtain
rvfv
pseudovirus
contain
rvfv
protein
confirm
pseudovirus
success
establish
obtain
rvfv
pseudovirus
serial
dilut
determin
infecti
titer
detect
result
show
rvfv
pseudoviru
titer
iuml
fig
show
posit
fluoresc
express
cell
incub
differ
fold
dilut
rvfv
pseudovirus
viru
infect
inhibit
assay
perform
evalu
whether
infect
abil
pseudovirus
could
inhibit
antirvfv
antibodi
shown
fig
incub
polyclon
antibodi
rvfv
protein
rvfv
pseudovirus
could
effect
infect
cell
wherea
vsv
pseudovirus
polyclon
antibodi
rvfv
protein
could
effect
defend
viru
infect
cell
therefor
antibodi
inhibit
assay
indic
infect
abil
rvfv
pseudovirus
could
inhibit
specif
antibodi
result
indic
obtain
rvfv
pseudovirus
could
bind
specif
antibodi
could
use
antigen
neutral
assay
thu
pseudovirus
could
effect
appli
antibodi
neutral
assay
rvfv
pseudovirus
react
serial
dilut
posit
mous
serum
measur
neutral
antibodi
titer
shown
tabl
posit
serum
sampl
mice
immun
rvfv
protein
neutral
activ
dilut
rang
indic
inhibit
rvfv
pseudoviru
infecti
activ
serum
dilut
neutral
viru
infect
serum
dilut
neutral
approxim
viru
infect
serum
dilut
neutral
approxim
viru
infect
howev
rvfvposit
mous
serum
inhibit
vsv
pseudoviru
infect
result
indic
rvfv
pseudoviru
neutral
assay
could
use
effect
measur
antibodi
neutral
thu
assay
could
use
evalu
antiinfect
immun
statu
human
rvfv
highrisk
pathogen
transmit
insect
bite
direct
contact
therefor
physic
manipul
pose
enorm
safeti
concern
veterinari
worker
laboratori
personnel
issu
sever
limit
studi
genom
structur
pathogen
mechan
rvfv
normal
circumst
vaccin
induc
high
neutral
antibodi
titer
human
neutral
antibodi
titer
import
indic
immun
effect
vaccin
howev
tradit
rvfv
viru
neutral
assay
involv
tediou
work
includ
cultur
viru
perform
biolog
safeti
level
laboratori
thu
limit
applic
neutral
assay
monitor
detect
diagnosi
rvfv
infect
evalu
effect
vaccin
rvfv
infect
therefor
safeti
issu
associ
rvfv
import
problem
drawn
consider
attent
issu
need
address
studi
target
highrisk
virus
rvfv
recent
pseudoviru
technolog
becom
effect
tool
scientif
research
demonstr
sever
uniqu
applic
advantag
exampl
experiment
studi
pseudovirus
use
replac
highrisk
virus
greater
pathogen
infect
rvfv
typic
exampl
compar
natur
virus
pseudoviru
particl
similar
pattern
cell
infect
pseudovirus
also
effect
simul
earli
cell
infect
process
natur
virus
addit
free
viral
dna
report
gene
ie
egfp
lacz
artifici
introduc
pseudovirus
approach
conduc
rapid
time
detect
analysi
clinic
furthermor
pseudovirus
exhibit
defect
replic
ensur
safe
manipul
avoid
risk
infect
pose
highrisk
virus
elimin
risk
seriou
safeti
concern
releas
laboratori
therefor
pseudovirus
use
studi
mechan
underli
viral
infect
host
cell
importantli
pseudovirus
use
replac
natur
virus
use
tradit
viru
neutral
assay
current
neutral
assay
incorpor
pseudovirus
becom
new
effect
rout
detect
neutral
antibodi
mani
type
current
establish
pseudovirus
avail
domest
intern
includ
middl
east
respiratori
syndrom
coronaviru
merscov
ebov
hepat
c
viru
sarscov
pseudovirus
success
appli
drug
screen
neutral
antibodi
activ
detect
evalu
vaccin
effect
current
pseudoviru
packag
system
primarili
develop
base
hiv
lentivir
vector
murin
leukemia
viru
advantag
broad
suitabl
host
rang
high
packag
effici
present
studi
use
lentivir
packag
system
recombin
express
plasmid
encod
rvfv
structur
protein
construct
rvfv
pseudovirus
electron
microscopi
observ
western
blot
result
indic
success
construct
rvfv
pseudovirus
addit
infect
activ
obtain
rvfv
pseudovirus
inhibit
specif
antibodi
indic
pseudovirus
could
use
detect
rvfvneutral
antibodi
titer
moreov
rvfv
pseudoviru
neutral
assay
establish
studi
effect
evalu
antibodi
titer
posit
mous
serum
pseudoviru
packag
experi
show
passag
time
statu
cell
transfect
reagent
plasmid
puriti
gene
featur
structur
protein
effici
eukaryot
express
plasmid
greatli
influenc
pseudoviru
packag
effici
affect
titer
level
stabil
packag
pseudovirus
therefor
pseudoviru
neutral
assay
establish
present
studi
use
clinic
monitor
diagnosi
rvfv
infect
assess
effect
rvfv
vaccin
furthermor
pseudoviru
use
replac
natur
viru
infect
mechan
studi
howev
packag
condit
optim
increas
lentivir
packag
effici
infect
titer
